Focus

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

Focus

Feb 7, 2025

Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances

In the era of the generative economy,Medidata is transforming how industries are empowering patients with new cure and care experiences and lifelong engagement

Focus

Feb 7, 2025

Channel Factory partners with Dentsu Japan International Brands to drive unmatched media efficiency for YouTube campaign

SINGAPORE,Feb. 5,2025--Dentsu Japan International Brands Inc. (DJIB),the leading agency in the Japanese advertising market,has partnered with Channel Factory,a specialist in contextual targeting and m

Focus

Feb 7, 2025

SunCar Technology Group Announces Pricing of $50 Million Follow-On Public Offering of Class A Ordinary Shares

NEW YORK,Feb. 6,2025-- SunCar Technology Group Inc. ("SunCar") (Nasdaq: SDA),an innovative leader in cloud-based B2B auto services and auto e-insurance in China,today announced the pricing o

Focus

Feb 7, 2025

Autohome Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

BEIJING,Feb. 6,2025-- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"),a leading online destination for automobile consumers in China,today announced that it wi

Focus

Feb 7, 2025

Strong stakeholder engagement towards Minesto's first tidal energy Dragon farm in Hestfjord, Faroe Islands

GOTHENBURG,Sweden,Feb. 6,2025-- On Monday 3rd February,ocean energy developer Minesto welcomed Faroese stakeholders,authorities as well as the public to a seminar at the Nordic House in Torshavn. Mart

Focus

Feb 7, 2025

1 ... 99 100 101 102 103 104 105 ... 138